
Opinion|Videos|September 30, 2024
Factors to Consider When Switching Therapies
The discussion covers when to consider transitioning to a new therapeutic option in CLL and the factors that influence the decision between dose modification and switching therapies.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- When is transitioning to a new therapeutic option considered, and what factors influence the decision between dose modification and switching therapies in chronic lymphocytic leukemia treatment?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Overcoming Barriers to Kidney-Protective Therapy
2
What Pharmacists Should Know About Novo Nordisk–Eli Lilly GLP-1 Ad Suit
3
Overlooked Coronavirus Protein May Drive Cytokine Storm, Cardiac Injury in Severe COVID-19
4
Biosimilars: A Guide for Pharmacists
5






























































































